MedTrace Logo

The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial

NCT00761423 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2017-05-18

No results posted yet for this study

Summary

The study will be a double-blind randomized single-center clinical trial comparing 3 treatment groups with chronic midportion Achilles tendinopathy.

Conditions

  • Achilles Tendinopathy

Interventions

BIOLOGICAL

PRP Injection with eccentric exercises

PRP Injection with eccentric exercises

BIOLOGICAL

Placebo Injection with eccentric exercises

Placebo Injection with eccentric exercises

Sponsors & Collaborators

Principal Investigators

  • RJ De Vos, MD · Erasmus Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-02-28
Completion
2009-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00761423 on ClinicalTrials.gov